A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Clinical trial NCT06075758 · COMPLETED
Trial details
- NCT number
- NCT06075758
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-07
- Primary completion
- 2025-06-30
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.